Serum Institute to produce 300 million doses of Sputnik V annually from September 2021
Technology transfer process has already started; cultivation process has begun following the approval by the Drug Controller General of India (DCGI)
Technology transfer process has already started; cultivation process has begun following the approval by the Drug Controller General of India (DCGI)